Clinical Effect, Analysis of Amoxicillin Clavulanate Potassium Combined with Shenling Baizhu Powder in the Treatment of Gastric Ulcer with Helicobacter pylori Infection

被引:0
|
作者
Wang, Ying [1 ]
Hou, Shu [1 ]
机构
[1] Chengdu Third Peoples Hosp, Phys Examinat Ctr, Dept Gastroenterol, Chengdu 610000, Sichuan, Peoples R China
关键词
Amoxicillin-clavulanate potassium; Shenling Baizhu powder; gastric ulcer; Helicobacter pylori; clinical efficacy;
D O I
10.36468/pharmaceutical-sciences.spl.500
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We attempt to investigate the improvement of clinical efficacy of amoxicillin-clavulanate potassium combined with Shenling Baizhu powder in treating gastric ulcer patients with Helicobacter pylori infection and the effect on related serum indexes. We selected 90 patients with gastric ulcer complicated with Helicobacter pylori infection in our hospital from January 2019 to May 2021 and randomly divided them into observation group (45 cases treated with amoxicillin clavulanate potassium combined with Shenling Baizhu powder) and control group (45 cases treated with amoxicillin-clavulanate potassium), compared both groups on the clinical effective rate and Helicobacter pylori eradication rate (per-protocol analysis) before and after treatment, the serum mucosal cytokines (vascular endothelial growth factor, epidermal growth factor, cyclooxygenase-2), matrix metalloproteinase and infection indicators (procalcitonin, C-reactive protein, interleukin-6) concentration level changes. After treatment, observation group possessed remarkably higher serum levels of vascular endothelial growth factor, epidermal growth factor and cyclooxygenase-2 than control group (p<0.05); it possessed remarkably lower procalcitonin, C-reactive protein and interleukin-6 serum levels than control group (p<0.05); and it possessed remarkably lower matrix metalloproteinase-7, matrix metalloproteinase-9 and matrix metalloproteinase plasma levels than control group (p<0.05); after per-protocol analysis, Helicobacter pylori radical cure rate of observation group (86.67 %) was remarkably higher than control group (66.67 %) (p<0.05). Amoxicillin-clavulanate potassium combined with Shenling Baizhu powder can significantly improve the clinical efficacy of gastric ulcer complicated with Helicobacter pylori infection, increase the clearance rate of Helicobacter pylori, increase the level of cellular and mucosal cytokines in serum and reduce the level of serum cytokines. The concentration levels of procalcitonin, C-reactive protein and interleukin-6 can provide clinical guidance value for effectively treating gastric ulcer with Helicobacter pylori infection.
引用
收藏
页码:131 / 135
页数:5
相关论文
共 50 条
  • [21] Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection
    Axon, ATR
    OMorain, CA
    Bardhan, KD
    Crowe, JP
    Beattie, AD
    Thompson, RPH
    Smith, PM
    Hollanders, FD
    Baron, JH
    Lynch, DAF
    Dixon, MF
    Tompkins, DS
    Birrell, H
    Gillon, KRW
    [J]. BRITISH MEDICAL JOURNAL, 1997, 314 (7080): : 565 - 568
  • [22] The diagnostic effect and clinical treatment value of white light endoscopy in gastric mucosa lesions of patients with Helicobacter pylori infection
    Wang, Yue
    Peng, Lianhong
    Hasanuowa, Haisilaiti
    Li, Ziqiong
    Awuti, Kuerban
    Yalikun, Patiguli
    Kelimu, Gulinigeer
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 : 40 - 40
  • [23] Associations between cytokine gene polymorphisms and susceptibility to Helicobacter pylori infection and Helicobacter pylori related gastric cancer, peptic ulcer disease: A meta-analysis
    Ma, Jingjing
    Wu, Dandan
    Hu, Xue
    Li, Jiao
    Cao, Mingwei
    Dong, Weiguo
    [J]. PLOS ONE, 2017, 12 (04):
  • [24] Effect of amoxicillin, clarithromycin, and rabeprazole, a new proton pump inhibitor, in eradication therapy for relapsing peptic ulcer diseases with Helicobacter pylori infection
    Hizawa, K
    Nakahara, T
    Yano, Y
    Inuzuka, S
    Akagi, K
    Matsumoto, T
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 31 (04) : 338 - 339
  • [25] Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer
    Labenz, J
    Tillenburg, B
    Peitz, U
    Verdu, E
    Stolte, M
    Borsch, G
    Blum, AL
    [J]. GUT, 1997, 41 (01) : 33 - 36
  • [26] Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients -: Results of a randomized controlled trial in Japan
    Habu, Y
    Mizuno, S
    Hirano, S
    Kiyota, K
    Inokuchi, H
    Kimoto, K
    Nakajima, M
    Kawai, K
    [J]. DIGESTION, 1998, 59 (04) : 321 - 325
  • [27] EFFECT OF TREATMENT OF HELICOBACTER-PYLORI INFECTION ON THE LONG-TERM RECURRENCE OF GASTRIC OR DUODENAL-ULCER - A RANDOMIZED, CONTROLLED-STUDY
    GRAHAM, DY
    LEW, GM
    KLEIN, PD
    EVANS, DG
    EVANS, DJ
    SAEED, ZA
    MALATY, HM
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 116 (09) : 705 - 708
  • [28] Treatment of Helicobacter pylori Infection With Intra-Gastric Violet Light Phototherapy: A Pilot Clinical Trial
    Lembo, Anthony J.
    Ganz, Robert A.
    Sheth, Sunil
    Cave, David
    Kelly, Ciaran
    Levin, Philip
    Kazlas, Peter T.
    Baldwin, Paul C., III
    Lindmark, William R.
    McGrath, Jonathan R.
    Hamblin, Michael R.
    [J]. LASERS IN SURGERY AND MEDICINE, 2009, 41 (05) : 337 - 344
  • [29] Haplotype analysis of the CD11 gene cluster in patients with chronic Helicobacter pylori infection and gastric ulcer disease
    Hellmig, S
    Mascheretti, S
    Renz, J
    Frenzel, H
    Jelschen, F
    Rehbein, JK
    Fölsch, U
    Hampe, J
    Schreiber, S
    [J]. TISSUE ANTIGENS, 2005, 65 (03): : 271 - 274
  • [30] Clinical observation of magnesium aluminum carbonate combined with rabeprazole-based triple therapy in the treatment of helicobacter pylori-positive gastric ulcer associated with hemorrhage
    Zhou, Peng-zhe
    Gao, Lei
    Wang, Li-wei
    Zhang, Ying-fu
    Song, Wei-li
    Hao, Ying-xia
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (05) : 1271 - 1277